Le Lézard
Classified in: Health
Subjects: PER, MAT

PharmaCielo Congratulates CEO Anthony Wile on Induction as Citizen of Colombia by Decree of President Santos


TORONTO and BOGOTÁ, Colombia, Aug. 3, 2018 /PRNewswire/ - PharmaCielo Ltd. is pleased to announce and extend congratulations to our CEO, Anthony Wile, who became a citizen of Colombia, conferred by presidential decree at a ceremony held August 2nd in the historic Palacio de San Carlos in Bogotá hosted by Minister of Foreign Affairs María Ángela Holguín.  The granting of citizenship recognizes Mr. Wile's significant contributions to Colombia and commitment to bringing Canada and Colombia closer together. 

PharmaCielo Canadian CEO Anthony Wile receives Colombian Citizenship from Foreign Minister María Ángela Holguin. (CNW Group/PharmaCielo)

A successful entrepreneur and author on economics and the financial markets, over the past 15 years Mr. Wile has been active in a number of Colombian business initiatives including in the mining industry, real estate and broader agricultural sector.  Most recently, his efforts have focused on development of the newly established medicinal cannabis industry through leadership of PharmaCielo, Colombia's first fully licensed and operational cultivator and processor of medicinal cannabis oil extracts.

"I would like to thank President Santos and his administration for bestowing upon me this tremendous honour," said Mr. Wile. "I had no idea when I first arrived in Colombia more than 15 years ago that it would touch me so deeply and in so many ways. The more I have gotten to know the culture of this great country the more I have fallen in love with it. I am proud to become a Colombian citizen and again want to thank President Santos and Ministra Holguín for this great privilege."

Fluent in both Spanish and English, Mr. Wile becomes a Colombian citizen while retaining his Canadian citizenship. He was born in Nova Scotia, Canada, and had a traditional Canadian upbringing. He studied business at university before becoming involved in multiple business initiatives within the financial marketplace and seeking out additional opportunities throughout the world, eventually focusing his attention on Colombia and its people more than 15 years ago.

"Anthony has always demonstrated a sincere commitment to Colombia's people. When we worked together to establish PharmaCielo, one of his first initiatives was to also establish Fundación PharmaCielo, which seeks to extend the future benefits of our new business venture among Colombian campesinos and indigenous people alike," noted Federico Cock-Correa, President and Director of PharmaCielo Colombia Holdings Ltd.  "I know that he will continue to make contributions in the years ahead."

About PharmaCielo

PharmaCielo Ltd. is a global company privately held and headquartered in Canada, with a focus on processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its Nursery and Propagation Centre located in Rionegro, Colombia.

The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia's ideal location will play in building a sustainable business in the medical cannabis industry, and the company, together with its directors and executives, has built a compelling business plan focused on supplying the international marketplace.

www.PharmaCielo.com

PharmaCielo (CNW Group/PharmaCielo)

SOURCE PharmaCielo


These press releases may also interest you

at 23:19
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...



News published on and distributed by: